Relationship of triglyceride-glucose index with cardiometabolic multi-morbidity in China: evidence from a national survey

Table 2 The association of TyG index with CMM

TyG index	Total N	No. of events (Incident rate^#)	Model 1		Model 2		Model 3
TyG index	Total N	No. of events (Incident rate^#)	HR (95% CI)	P value	HR (95% CI)	P value	HR (95% CI)	P value
Continues
Per 1.0 increase	7970	638 (11.63)	1.76 (1.60–1.94)	< 0.001	1.51 (1.34–1.69)	< 0.001	1.54 (1.29–1.84)	< 0.001
Quartiles
Q1 (≤ 8.22)	1992	84 (6.17)	Ref.		Ref.		Ref.
Q2 (> 8.22 to 8.59)	1993	122 (8.87)	1.44 (1.09–1.90)	0.010	1.39 (1.03–1.88)	0.031	1.30 (0.96–1.77)	0.095
Q3 (> 8.59 to 9.03)	1993	175 (12.75)	2.08 (1.60–2.70)	< 0.001	1.57 (1.18–2.10)	0.002	1.41 (1.05–1.90)	0.024
Q4 (> 9.03)	1992	257 (18.91)	3.13 (2.44-4.00)	< 0.001	2.07 (1.56–2.74)	< 0.001	1.61 (1.18–2.20)	0.003
P for trend				< 0.001		< 0.001		0.028

Model 1: unadjusted
Model 2: adjusted for age, sex, SBP, DBP, BMI, alcohol consumption and smoking status
Model 3: model 2 + further adjusted for marital status, education, rural residence, heart rate, BUN, serum creatinine, UA, hemoglobin, TC, LDL, stroke, heart disease, and DM
BMI, body mass index; BUN, blood urea nitrogen; CI, confidence interval; CMM, cardiometabolic multimorbidity; DBP, diastolic blood pressure; DM, diabetes mellitus; HR, hazard ratio; LDL, low density lipoprotein; Q, quartile; Ref, reference; SBP, systolic blood pressure; TC, total cholesterol; UA, uric acid
^#Incident rate was presented as per 1000 person-years of follow-up

ISSN: 1758-5996